相关实验视频

Updated: Sep 13, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.7K

外体PD-L1在NSCLC免疫治疗中的作用

Zhu Li1, Shichang Zhang1, Yue Wang1

  • 1Pharmacology and Toxicology, Wright State University, Fairborn, OH, USA.

Immunotherapy
|July 30, 2025
PubMed
概括

外体编程死亡配体1 (PD-L1) 促进非小细胞肺癌 (NSCLC) 的进展和治疗耐药性. 向外体生物发生提供了一种新的策略,以克服NSCLC的免疫疗法抵抗性.

关键词:
免疫逃避是一种免疫逃避.在NSCLCLC中,我们可以看到.在外体PD-L1中.免疫疗法 免疫疗法治疗抗药性是一种治疗抗药性.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

548
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.3K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662